Since β-adrenergic ligands affected both gene expression of GIRK1 and cell proliferation for breast cancer cell lines in our laboratory [10], we wanted to determine if β-adrenergic agonists and antagonists had effects on either gene expression or cell proliferation in SCLC cells. This evidence concerns the gene KCNJ3 and breast carcinoma.